SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

AstraZenecas reported Baxfendy sales have traders questioning how quickly the new aldosterone-inhibitor class can gain coverage and commercial traction, weighing on expectations for Mineralys planned launch. Some see the early sales as a normal reimbursement ramp for a chronic treatment, while others worry that a slow launch and competition could constrain lorundrostats sales potential.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of Voceryq, a competing treatment for recurrent respiratory papillomatosis, has put pressure on Precigens PAPZIMEOS and raised concerns about competition. Traders debate the threat to Precigens sales against its first-mover and full-approval advantages, while noting Voceryqs accelerated-approval status and commercialization hurdles.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is drawing attention after Piper Sandler lowered its price target, keeping a Neutral rating while pointing to concerns that networking growth may be peaking and valuations could compress. Traders are debating whether the selloff is justified or an overreaction, with bulls pointing to continued AI-infrastructure demand and bears focused on weak price action.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,617.445403. The last known price of Zebec Network is 0.00204055 USD and is down -0.09 over the last 24 hours. It is currently trading on 133 active market(s) with $10,537,951.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Traders are focused on reported MoneyGram connectivity and Zebecs broader payroll and payments expansion, viewing real-world adoption and potential token demand as bullish catalysts. Others remain skeptical, pointing to weak price follow-through and questioning whether business growth will translate into sustained ZBCN usage or buybacks.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 data for Amgens IMDELLTRAImfinzi combination in small-cell lung cancer is supporting bullish attention as shares reach a fresh high, with traders also focused on the upcoming earnings report and a Sjgrens disease readout. Put-heavy options activity is being debated as possible earnings hedging rather than a clear bearish bet, alongside call buying and momentum interest.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIMs attention is centered on its higher full-year outlook, which traders link to persistently strong container freight rates and demand, boosting expectations for earnings and dividends. The community is also debating whether Hapag-Lloyds acquisition can clear Israeli regulatory objections, with some favoring a sale and others preferring standalone cash generation and dividends.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a 52-week high ahead of the expected Q3 report has traders focused on BRIUMVIs sales momentum, while unconfirmed buyout speculation and call-heavy options activity add to the buzz. The community is split on whether the rally reflects earnings positioning and potential short covering or anticipation of a deal; no buyout has been confirmed.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons agreed sale of its Eagle Ford assets to Crescent is driving attention, following earlier speculation about asset divestitures and pressure to streamline the company after its Coterra merger. Traders are divided on whether the sale improves focus and capital allocation, with some questioning why the shares have not responded more strongly.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders react to a sharp tech-led Nasdaq selloff and falling futures, with worries about AI spending returns and disappointing tech results reinforcing bearish bets. Many are buying or holding SQQQ as a hedge, while others warn that the leveraged ETF can reverse quickly; separate Iran-deal chatter remains unverified and contested.

3M Co. is a technology company, which engages in manufacturing industrial, safety, and consumer products. It operates through the following segments: Safety and Industrial, Transportation and Electronics, Consumer, and Corporate. The Safety and Industrial segment consists of personal safety, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules. The Transportation and Electronics segment includes electronics, automotive and aerospace, commercial solutions, advanced materials, and transportation safety. The Consumer segment covers consumer healthcare, home care, home improvement, and stationery and office products, such as consumer bandages, braces, supports, respirators, cleaning products, retail abrasives, picture hanging, and consumer air quality solutions. The Corporate segment refers to special items and other corporate expenses. The company was founded by Henry S. Bryan, Hermon W. Cable, John Dwan, William A. McGonagle, and J. Danley Budd in 1902 and is headquartered in St. Paul, MN.

3M Co.

3Ms earnings beat and raised outlook, alongside its expanded Amazon data-center partnership, are driving attention. Bulls see the deal as a growth opportunity, while skeptics note that Amazons purchase threshold is conditional and call the rally overdone, with bearish traders discussing puts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced its participation at the 2026 Neuroscience Education Institute (NEI) Fall Congress, taking place in Colorado Springs, CO, from November...

Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the third quarter ended September 30, 2026, and provide an update on recent developments, on...

Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the first-ever TRD Awareness Day in the U.S., a day dedicated to recognizing and advocating for individuals, caregivers and communities...

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

Equity

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

Compass Pathways Reports Q2 2026 Results: Full Earnings Call Transcript

Compass Pathways (NASDAQ:CMPS) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below.
This content is powered by Benzinga APIs. For comprehensiveread more...

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to one senior leader and ten newly hired...

Compass Pathways Appoints Kelley Boucher as Chief People Officer

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced the appointment of Kelley Boucher as Chief People Officer, effective today. This appointment strengthens the Compass executive team as the...

Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026 and will participate...

Compass Pathways Launches Change the Tune in TRD in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of...

Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training

Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training PR Newswire NEW YORK, Sept. 10, 2026 New certificate program will prepare clinicians to support patients receiving COMP360...

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

Neutral Sentiment

<ul class="summary-bullets"><li>The selling was concentrated across several of Ark's ETFs rather than limited to one part of the portfolio.</li><li>ARK Innovation ETF pared its stake in five prominent companies, namely, SpaceX, AMD, Alphabet, Robinhood Markets and Shopify.</li><li>The buying activity was concentrated in ARKG, where Ark added positions across a broad group of biotechnology companies rather than concentrating its purchases in a single stock.</li></ul>Cathie Wood-led Ark Invest reshuffled several of its holdings Friday, selling a number of prominent technology and growth names while adding to a wide range of biotechnology stocks.The trades put some of Ark's better-known holdings on the sell side, including Advanced Micro Devices Inc. (AMD), Alphabet Inc. (GOOG) and Space Exploration Technologies Corp. (SpaceX), while its genomics-focused ARK Genomic Revolution ETF (ARKG) continued to add to biotech companies.<h2 class="st-heading-2">Ark Pares AMD, SPCX, GOOG Stakes</h2>The selling was concentrated across several of Ark's ETFs rather than limited to one part of the portfolio.ARK Innovation ETF (<a class="mention" data-mention="$ARKK" data-symbol-id="ARKK" href="https://stocktwits.com/symbol/ARKK" target="_blank">ARKK</a>) pared its stake in five prominent companies, namely, SpaceX, AMD, Alphabet, Robinhood Markets Inc. (HOOD) and Shopify Inc. (SHOP).The trades extended beyond technology. ARK Blockchain &amp; Fintech Innovation ETF (ARKF) sold the ARK 21Shares Bitcoin ETF (ARKB) and DraftKings Inc. (DKNG), while ARKG reduced positions in Personalis Inc. (PSNL) and CareDx Inc. (CDNA). ARK Space &amp; Defense Innovation ETF (ARKX) sold Iridium Communications Inc. (IRDM).Among the technology names, the transactions included both semiconductor and internet exposure, with AMD, Alphabet and Shopify all appearing among ARKK's sales.<h2 class="st-heading-2">ARKG Adds Across Biotech</h2>The buying activity was concentrated in ARKG, where Ark added positions across a broad group of biotechnology companies rather than concentrating its purchases in a single stock.The purchases included gene-editing companies CRISPR Therapeutics AG (CRSP), Intellia Therapeutics Inc. (NTLA) and Beam Therapeutics Inc. (BEAM).Other companies which saw buying activity from ARKG included Nurix Therapeutics Inc. (NRIX), Guardant Health Inc. (GH), Kymera Therapeutics Inc. (KYMR), Compass Pathways PLC (CMPS), Alamar Biosciences Inc. (ALMR) and Freenome Inc. (FRNM).ARK Autonomous Technology &amp; Robotics ETF (ARKQ) also bought shares of Symbotic Inc. (SYM) and Kodiak AI Inc. (KDK).<a href="https://stocktwits.com/symbol/ARKG">ARKG’s price</a> closed up over 4% in Friday’s regular trading session and rose nearly 0.4% during the after-hours trade. Retail sentiment on Stocktwits around ARKG trended in the ‘bearish’ territory at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spcx-spectrum-deal-raises-asts-value-telecom-stocks/cZxTkNERBnp">SpaceX's Spectrum Deal Could Boost AST SpaceMobile’s Strategic Value — Analyst Calls ASTS 'Natural Satellite Partner' For Carriers</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cathie Wood, CEO & Chief Investment Officer of ARK Invest, speaks onstage during Day 2 of 2023 Invest Fest at Georgia World Congress Center on August 27, 2023 in Atlanta, Georgia. (Photo by Paras Griffin/Getty Images)

Alamar Biosciences Inc.

Advanced Micro Devices Inc

ARK 21Shares Bitcoin ETF

ARK Investment Management LLC - ARK Genomic Revolution ETF

ARK Innovation ETF

ARK Autonomous Technology & Robotics ETF

ARK Space Exploration & Innovation ETF

Beam Therapeutics Inc

Caredx Inc

COMPASS Pathways

CRISPR Therapeutics AG

DraftKings Inc

Freenome, Inc.

Guardant Health Inc

Alphabet Inc - Ordinary Shares - Class C

Robinhood Markets Inc

Iridium Communications Inc

Kodiak AI Inc. - Ordinary Shares - Class A

Kymera Therapeutics Inc

Nurix Therapeutics Inc

Intellia Therapeutics Inc

Personalis Inc

SpaceX

Symbotic Inc

$CMPS

$SOUN

$MRNA

$LCID

Compass Pathways ($CMPS), SoundHoundAI ($SOUN), Moderna ($MRNA), and Lucid Group ($LCID) are four of the most searched and talked-about stocks among retail investors this morning. Which are you most bullish? Drop your reasoning in the comments.

Which of these trending stocks are you most bullish on for the next 5 years - $CMPS, $SOUN, $MRNA, or $LCID?

Current Price	$11.57
Prev Close	$12.19
Open	$11.82
Dividend Yield	0.00%
50-Day Moving Average	$12.91
Beta	1.43
Avg. Volume	2.85M
PE Ratio	-2.50

52-Week High	$15.87
52-Week Low	$4.88
Market Capitalization	$1.6B
EPS (Annual)	-$3.09
Price to Book	18.58
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

CMPS Fundamentals